SEQH Capital Research

SEQH Capital Research

FERMI AMERICA HYPERGRID CAMPUS: DUAL-FACILITY ECONOMIC MODEL

2/21/26

SEQH Capital Research's avatar
SEQH Capital Research
Feb 21, 2026
∙ Paid

SEQH Capital Research
Fermi America HyperGrid Campus: Dual-Facility Economic Model
Tear Sheet – February 21, 2026


Why This Report Exists

Fermi America’s HyperGrid Campus in Amarillo, Texas co-locates HALEU enrichment and stable isotope production adjacent to the DOE’s Pantex Plant. This report quantifies the 2.87 billion dollar NPV generated on just 795 million dollars of capital deployed, a 3.61x multiple, and demonstrates that the market is pricing ASPI at less than 20% probability of success.​


The Pantex Adjacency Moat

The Pantex Plant’s existing Category I/II Special Nuclear Material licenses, hardened security infrastructure, and DOE/NRC coordination frameworks create a permanent, unreplicable regulatory advantage.​

  • Licensing timeline compressed by 76 months (6.3 years) per facility, a 52% reduction vs. greenfield.​

  • Regulatory cost savings of 52 million dollars per facility (53% reduction). Total dual-facility regulatory arbitrage: 104 million dollars.​

  • This moat cannot be replicated by any competitor without access to a similarly pre-qualified DOE nuclear site.​


Facility 1: QLE HALEU Enrichment (JV)

  • 20 MTU/year HALEU enrichment plant (QLE/Fermi America JV).​

  • Includes 15 MTU/year TerraPower offtake agreement. HALEU demand CAGR of 35% through 2035.​

  • 10-year revenue projection: 5.05 billion dollars at 54% gross margin.​

  • Ramp: 30% utilization Year 1, 90% by Year 5.​

  • CapEx: 453 million dollars (reduced 6.6% via Pantex adjacency).​

  • 10-year NPV: 919.8 million dollars (2.04x NPV-to-capital multiple).​


Facility 2: ASPI Stable Isotopes (100% Owned)

  • Diversified portfolio of eight high-value isotopes (Si-28, Yb-176, C-14, etc.) for semiconductor, medical, and industrial markets.​

  • Annual revenue at full ramp: 955.5 million dollars at 65% gross margin.​

  • 10-year revenue: 7.85 billion dollars. Ramp to 95% utilization by Year 8.​

  • CapEx: 310.5 million dollars.​

  • 10-year NPV: 1.837 billion dollars (5.15x NPV-to-capital multiple, highest-return component).​


Co-Location Synergies

  • Shared infrastructure CapEx savings: 61.0 million dollars (38.8% reduction vs. standalone).​

  • Annual recurring OpEx savings: 9.4 million dollars (10-year PV of 53.1 million dollars).​

  • Total incremental co-location value: 114.1 million dollars.​

  • Additional strategic benefits: cross-selling, supply chain integration, enhanced customer confidence.​


Site Economics: Texas Wins

Texas vs. Pelindaba (South Africa) vs. Reykjavik (Iceland): while Iceland offers the lowest electricity costs, Texas provides the superior all-in cost per kilogram, saving 1,280 dollars per kg vs. South Africa and 380 dollars per kg vs. Iceland.​

The critical differentiator: Texas unlocks 100% of customer types including DOE, DOD, and NASA contracts inaccessible to foreign facilities, a 50–150 million dollar per year exclusive revenue opportunity.​


Consolidated Campus Economics

  • Total CapEx: 794.5 million dollars.​

  • Total 10-year NPV: 2.871 billion dollars (3.61x NPV-to-capital multiple, 9.13x cash-on-cash).​

  • Bear case (30% underperformance): 2.044 billion dollars NPV, 2.57x return.​

  • Bull case: 3.56 billion dollars NPV.​


Implications for ASPI Equity

  • ASPI market cap: ~280 million dollars. ASPI attributable campus NPV: 2.3 billion dollars.​

  • At 100% probability: 8.2x upside on current market cap.​

  • At 50% probability: 4.1x upside (1.148 billion dollars attributable value).​

  • Market is pricing in <20% probability of success despite signed MOU, secured DOE site adjacency, and proven ASP technology.​


Key Risks

  • QE technology unproven on uranium at commercial scale.​

  • Multi-year regulatory and licensing execution risk even with Pantex adjacency.​

  • 795 million dollar total capital deployment required, financing structure not yet fully defined.​

  • HALEU market pricing and demand realization uncertainty.​

  • Stable isotope market competition from Rosatom and potential Western entrants.​


SEQH View

The Fermi America HyperGrid Campus is a structurally advantaged, financially compelling opportunity with a permanent regulatory moat. The dual-facility model is economically optimal and dramatically underpriced by the market. The risk/reward profile is profoundly asymmetric, any upward revision in the market’s perception of project probability creates significant alpha for ASPI shareholders.​


Want the Full Dual-Facility Economic Model?

[READ THE COMPLETE HYPERGRID CAMPUS ANALYSIS]

The full report includes proprietary modeling unavailable elsewhere:

  • Complete 10-year pro-forma P&L for both the QLE HALEU facility and ASPI isotope facility with year-by-year utilization ramp

  • Pantex adjacency regulatory advantage quantification with timeline compression and cost savings breakdowns

  • Dual-facility co-location synergy analysis with shared infrastructure CapEx and recurring OpEx savings

  • Comparative site economics: Texas vs. South Africa vs. Iceland with all-in production cost and addressable market mapping

  • Consolidated NPV waterfall analysis with bear/base/bull sensitivity scenarios

  • ASPI equity holder attribution framework with probability-weighted upside multiples

  • DOE/DOD/NASA contract eligibility analysis exclusive to the domestic Texas location

  • Eight-isotope portfolio revenue buildup with individual margin profiles and market sizing

The market is pricing ASPI at <20% probability on a campus with a 3.61x NPV-to-capital multiple. This report gives you the math to decide if that’s mispriced.

Available exclusively to SEQH Capital Research paid subscribers. Upgrade to access →

User's avatar

Continue reading this post for free, courtesy of SEQH Capital Research.

Or purchase a paid subscription.
© 2026 SEQH Capital Partners · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture